Skip to content

PRETTINEO PREmedication Trial for Tracheal Intubation of the NEOnate - PRETTINEO

PRETTINEO PREmedication Trial for Tracheal Intubation of the NEOnate - PRETTINEO

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-014885-25-FR
Enrollment
Unknown
Registered
2011-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of two premedication regimens for semi-elective or elective intubation of newborns (term and preterm) hospitalized in the NICU MedDRA version: 13.1 Level: PT Classification code 10067450 Term: Endotracheal intubation System Organ Class: 10042613 - Surgical and medical procedures MedDRA version: 13.1 Level: PT Classification code 10036500 Term: Premedication System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: atropine Pharmaceutical Form: Solution for injection Pharmaceutical form of the placebo: Solution for injection Route of administration of the placebo: Intravenous use Trade Name: tracriu

Sponsors

Centre Hospitalier Intercommunal de Créteil
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Any newborn (corrected age =65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: No parental consent Previous sedative or analgesic treatment administration in the past 24 hours Hemodynamic compromise defined as mean arterial blood pressure (in mm Hg) 3 seconds Obvious upper airway malformation making intubation potentially difficult Life threatening situation requiring immediate intubation without premedication Participation to another therapeutic clinical trial disallowing any other therapeutic trial Impossibility to have reliable and safe IV access

Design outcomes

Primary

MeasureTime frame
Main Objective: The objective is to show that propofol, when compared to the association of atropine-atracurium-sufentanil as a premedication prior to endotracheal intubation, will decrease the number of desaturations defined as transcutaneous O2 saturation value below 80% for one minute or more ;Secondary Objective: Total duration of intubation, number of attempts and vital signs variations will be analyzed and compared between groups. Short term neurological surveillance will be based on head ultrasounds performed before and after intubation. For longer term outcome, a neurodevelopmental assessment will be performed in each center. If clinical evaluation is impossible, a phone survey will be performed at 4 months, one year and two years corrected age according to a standardized questionnaire ;Primary end point(s): Number of desaturations during the intubation procedure. Desaturations are defined as transcutaneous O2 saturation value below 80% for one minute or more

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026